Immunohistochemical Study Breast Cancer

dc.contributor.authorUmida Ismailova Abdullayevna
dc.contributor.authorNodira Tursunova Isroilovna
dc.contributor.authorDilbar Almuradova Muradovna
dc.contributor.authorKurbankulov Uktam Muhammadovich
dc.contributor.authorJumanazarov Azizbek Ulugbekovich
dc.date.accessioned2026-01-01T10:18:55Z
dc.date.issued2024-05-08
dc.description.abstractBreast cancer requires adequate diagnosis at the preoperative stage and a certain scheme of investigation of surgical and biopsy material. The prognosis and further tactics of treatment of patients depend on the result of histological examination with determination of receptor status (IHC-study) of breast cancer. Static data of breast cancer detection with the use of IHC-study on the basis of Tashkent City Dispensary for the period of 2020-2022 are indicated in the article.
dc.formatapplication/pdf
dc.identifier.urihttps://zienjournals.com/index.php/tjms/article/view/5271
dc.identifier.uri10.62480/tjms.2024.vol32.pp21-23
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/59841
dc.language.isoeng
dc.publisherZien Journals
dc.relationhttps://zienjournals.com/index.php/tjms/article/view/5271/4321
dc.rightshttps://creativecommons.org/licenses/by-nc/4.0
dc.sourceTexas Journal of Medical Science; Vol. 32 (2024): TJMS; 21-23
dc.source2770-2936
dc.subjectBreast cancer
dc.subjectimmunohistochemical study
dc.subjectmolecular genetic subtype of breast cancer
dc.titleImmunohistochemical Study Breast Cancer
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
abdullayevna_2024_immunohistochemical_study_breast_cancer.pdf
item.page.filesection.size
243.54 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections